AZN News and Press, AstraZeneca PLC

2024-07-21 08:01:00 ET More on related stocks: Visa Earnings: A Good Quarter Could Still Mean A Muted Share Price Response Danaher Q2: Inventory Overhang, But Low Expectations Limit Downside Why Truist Financial Stock Is Not A Buy Ahead Of Q2 Earnings Ford st...

2024-07-21 07:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Bristol-Myers Squibb - Investors Are Too Long-Term Focused Bristol-Myers Squibb Is A Bargain Now AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings Dividend Roundup: Gold...

2024-07-20 15:58:00 ET Amidst the flurry of corporate announcements this earnings season, the financial markets witnessed a spectrum of performances across various sectors. As the spotlight turns to the latest financial disclosures, the resilience of the U.S. economy remains a focal point a...

2024-07-20 00:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-19 15:00:00 ET More on the markets S&P 500: AI Funding Is Needed Amid Inflation And Federal Debt Fed Needs To Cut Rates Immediately Game-Changing CPI Report May Drive Big Rotation Towards Value And SmallCap Not the time to buy the dip - Goldman's ...

2024-07-19 06:50:00 ET Summary Parnassus Growth Equity Fund (Investor Shares) returned 3.74% (net of fees) for the quarter, underperforming the Russell 1000 Growth Index’s 8.33%. The underperformance was primarily driven by our stock selection in the Information Technology ...

2024-07-18 13:50:41 ET Summary AstraZeneca PLC will announce its Q2 earnings next Thursday, 25th July. In Q1, the company showed 19% year-on-year revenue growth and 13% EPS growth. Guidance for 2024 is for double-digit growth at the top and bottom lines — it's possible ...

2024-07-18 13:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. International equities...

2024-07-17 04:42:00 ET Summary As medical companies leverage the power of artificial intelligence, genomics, and other groundbreaking discoveries, the boundaries between technology and healthcare continue to blur, presenting potential opportunities for both patients and investors. ...

2024-07-15 10:51:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As good as the S&P 500 is performing in 2024, the Nasdaq 100 is doing even better. The tech-oriented index is up 23% this year, compared to an 19% gain by the benchmark index. I...